Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis

Sonu Kashyap1, Kyaw Zaw Hein1, Claudia Cs Chini1

  • 1Department of Anesthesiology and Robert and Arlene Kogod Center on Aging.

JCI Insight
|January 29, 2020
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) involves increased Pregnancy-associated plasma protein A (PAPP-A), which drives cyst growth. Inhibiting PAPP-A activity offers a potential new therapy for ADPKD.

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of end-stage renal disease (ESRD) with limited treatment options.
  • IGF-1 pathway gene upregulation was observed in ADPKD mouse models.
  • Pregnancy-associated plasma protein A (PAPP-A) increases local IGF-1 bioactivity by cleaving IGF binding proteins.

Purpose of the Study:

  • To investigate the role of PAPP-A in ADPKD pathogenesis.
  • To explore PAPP-A as a therapeutic target for ADPKD.

Main Methods:

  • Analysis of PAPP-A levels in ADPKD mouse models and human samples.
  • Investigating PAPP-A transcriptional regulation via the cAMP/CREB/CBP/p300 pathway.
  • Evaluating the therapeutic potential of PAPP-A inhibition using monoclonal antibodies in preclinical ADPKD models.

Main Results:

  • PAPP-A was highly induced in the kidneys of ADPKD mice and elevated in human ADPKD cystic fluid and kidneys.
  • PAPP-A deficiency ameliorated cyst development in Pkd1RC/RC mice.
  • Monoclonal antibody treatment blocking PAPP-A activity reduced ADPKD cyst progression in vivo and ex vivo.

Conclusions:

  • The PAPP-A/IGF-1 pathway is crucial for ADPKD cyst growth and expansion.
  • Inhibiting PAPP-A's proteolytic activity presents a promising therapeutic strategy for ADPKD.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K